Immune Disorders

News and Features

news

The table below is a review of notable updates that occurred in July 2023 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

news

The table below is a review of notable updates that occurred in May 2023 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

news

Panel votes unanimously in favor of an over-the-counter change for contraceptive pill; First pharmacological therapy for agitation associated with dementia due to Alzheimer disease; Elfabrio approved for the treatment of Fabry disease; Farxiga approval expanded; Bacterial contamination concerns for certain COVID-19 at-home tests.